Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Johnson & Johnson (

Opioid settlement payouts are now public — and we know how much local governments got

KFF Health News obtained documents showing the exact dollar amounts — down to the cent — that local governments have been paid in 2022 and 2023 in lawsuit settlements from the opioid crisis.

WEKU

Future Fortune 500 CEOs: 11 up-and-comers that leadership experts see as generational standout bosses

Fortune has identified 11 CEO stars in the making—many of them already in the C-suite, and all potential large-company CEOs.

Fortune

Ex-chief judge seeks best deal for pelvic mesh victims

"It was impossible not to be affected by the poignant stories told."

Newcastle Herald

From analysis to the latest developments in health,
read the most diverse news in one place.

Johnson & Johnson (JNJ) and SNDL Inc. (SNDL) -- Buy or Sell?

Investing in healthcare stocks could help hedge against economic downturns. Thus, Johnson & Johnson (JNJ) could be worth buying. However, I think SNDL (SNDL) is best avoided considering its weak fundamentals. Read on.

StockNews.com

Short Sellers Won't Bet Against Eight Rock-Solid Buffett-Like Stocks

Short sellers aren't afraid of many stocks in the S&P 500. But one stock they won't touch is Warren Buffett's Berkshire Hathaway.

Investors Business Daily

Protagonist, A Top 1% Biotech, Briefly Breaks Out On Psoriasis Enthusiasm

Shares of PTGX stock briefly broke out Friday after Protagonist said it plans to soon present new test results for its psoriasis drug.

Investors Business Daily

Johnson & Johnson Spins Off Kenvue in Biggest IPO Haul Since 2021

Johnson & Johnson rips off Band-Aid and spits out Listerine in a bid to boost margins.

Kiplinger

Read news from The Economist, FT, and more,
with one subscription

2 Remaining AAA-Rated Companies Shine As U.S. Gets Downgraded

Lawmakers are playing chicken with the debt ceiling. Luckily there are still two U.S. S&P 500 companies left with AAA credit ratings.

Investors Business Daily

The Fed Is About To Raise Rates! Get Ready To Plan Your Next Move!

Here Are 2 Ideas Depending on How the Next Fed Announcement Goes.

Barchart

Attorney General Ken Paxton to investigate COVID-19 vaccine makers

Long an opponent of vaccine and mask mandates, the Republican said pharmaceutical companies may have misrepresented data. Pfizer strongly disagrees.

The Texas Tribune

Woodside boss blasts 'extremists' with 'deep pockets' for stopping gas projects, ASX flat, Star sacks 500 workers

Woodside Energy boss Meg O'Neill has used a speech at the National Press Club to criticise extremists for stopping gas projects, while the Australian share market trades flat after a lacklustre session on Wall Street overnight.

ABC News

Markets Today: Stock Index Futures Climb as China’s Economy Strengthens

Morning Markets June S&P 500 futures (ESM2 3) this morning are up +0.49% at a 2-month high, and June Nasdaq 100 E-Mini futures (NQM2 3) are up +0.79% at a 2-week high. U.S. stock index futures this morning are moderately higher on improved global economic prospects after today’s news that...

Barchart

These 10 Crummy Stocks Already Cost Investors $300 Billion

What's worse than missing out on the five stocks driving the entire S&P 500 this year? Owning the ones that are dragging it down.

Investors Business Daily

US pharma giant Johnson & Johnson seeks to settle baby powder case

US pharmaceutical giant Johnson & Johnson has offered to pay almost $9 billion to settle tens of thousands of lawsuits alleging that its talcum powder caused ovarian cancer. If approved by a court in the US state of New Jersey, the payout would be one of largest liability settlements in…

France 24

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Rises, Nasdaq Falls As Investors Pour Into Gold; Health Care Stock Breaks Out

Johnson & Johnson raised its proposed combined settlement for thousands of talc cancer cases. Google's touts its AI chip model capabilities.

Investors Business Daily

Johnson & Johnson Pops After Sweetening Its Talc Settlement By Nearly $7 Billion

J&J reached an $8.9 billion settlement in ongoing litigation over its talc-based baby powders, leading JNJ stock to rise Wednesday.

Investors Business Daily

Dow Jones Reverses After ADP Jobs Data; C3.ai Continues To Plunge After Short-Seller Letter

The Dow Jones reversed higher Wednesday morning after ADP's jobs data. AI stock C3.ai plunged another 12% after Tuesday's short-seller letter.

The Guardian - UK

First Thing: Trump attacks hush money case in grievance-filled Mar-a-Lago speech

Former president appeared subdued in New York, only to return to his inflammatory ways in Florida. Plus, the campaigners using using dating apps to boost voter turnout

Get all your
news in one place.

100’s of premium titles.
One news app.

Daily Mirror

Johnson & Johnson offers $9billion to settle talcum powder cancer claims

Johnson & Johnson is reportedly facing over 40,000 lawsuits from customers who claimed using the company's talc-based baby powder caused cancer

Barchart

Here's 3 Dividend Companies That Just Crossed Above Their 50 Moving Average

Trading Smarter, Not Harder With the 50-Day Moving Average Strategy

WEKU

Johnson & Johnson proposes paying $8.9 billion to settle talcum powder lawsuits

Under a proposal, a J&J subsidiary will re-file for bankruptcy protection and seek court approval for a plan that would result in one of the largest product-liability settlements in U.S. history.

Chicago Sun-Times

Johnson & Johnson proposes $8.9 billion payout to settle talcum powder lawsuits

A subsidiary of the company will re-file for Chapter 11 bankruptcy protection and seek court approval for a plan that would result in one of the largest product-liability settlements in U.S. history.

Investors Business Daily

Dow Jones Futures: AI Stock Keeps Sliding; Johnson & Johnson Rises

Futures: The indexes held up OK Tuesday amid recession fears, but breadth was weak. AI stock C3.ai kept falling overnight. J&J stock rose..

WEKU

As states start to get opioid settlement cash, few are sharing how they spend it

All told, drugmakers and distributors will pay over $50 billion to communities harmed by opioids. An investigation finds that only a dozen states are letting the public see how they use the money.

Investors Business Daily

J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out

Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out.

1 … 7 8 9 10

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations